Manuela Pardeo

Drug Retention Rate and Predictive Factors of Drug Survival for Interleukin-1 Inhibitors in Systemic Juvenile Idiopathic Arthritis

Jurgen Sota, Antonella Insalaco, Rolando Cimaz et al. · Frontiers in Pharmacology · 2019 · 616 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +13

Anakinra as first‐line disease‐modifying therapy in systemic juvenile idiopathic arthritis: Report of forty‐six patients from an international multicenter series

Peter A. Nigrović, Melissa L. Mannion, Femke H. M. Prince et al. · Arthritis & Rheumatism · 2010 · 464 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +10

ADA2 deficiency (DADA2) as an unrecognised cause of early onset polyarteritis nodosa and stroke: a multicentre national study

Roberta Caorsi, Federica Penco, Alice Grossi et al. · Annals of the Rheumatic Diseases · 2017 · 260 citations · Full text

Medicine, Molecular Genetics, Neurology +12

Efficacy and safety of emapalumab in macrophage activation syndrome

Fabrizio De Benedetti, Alexei A. Grom, Paul Brogan et al. · Annals of the Rheumatic Diseases · 2023 · 141 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +14

Is serum troponin T a useful marker of myocardial damage in newborn infants with perinatal asphyxia?

Simonetta Costa, Enrico Zecca, Gabriella De Rosa et al. · Acta Paediatrica · 2007 · 90 citations

Medicine, Clinical Sciences, Pediatrics +17